We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Pegylated interferon alfa-2b treatment for patients with solid tumors: a phase I/II study.
- Authors
Bukowski, Ronald; Ernstoff, Marc S; Gore, Martin E; Nemunaitis, John J; Amato, Robert; Gupta, Samir K; Tendler, Craig L
- Abstract
The efficacy of interferon alfa has been established in treating advanced melanoma and renal cell carcinoma (RCC) patients. We conducted a phase I/II study to determine the maximum-tolerated dose (MTD), the safety and tolerability, and the preliminary efficacy of once-weekly pegylated interferon alfa-2b (IFNalpha-2b) in patients with advanced solid tumors (primarily RCC).
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Vol 20, Issue 18, p3841
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.2002.02.051